CEO share program- Correction
Medistim ASA (MEDI) · publisert 17. april 2026 kl. 18:20 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| K2 Consulting AS | – | other Overføring | 44 500 | – | – | – | – | llm |
Meldingstekst
It was reported earlier today that K2 Consulting AS had 44500 after the transfer of shares to the CEO controlled company. The correct number of share after the transfer are 43500 shares. After the transfer the CEO controls 90583 as reported earlier.